CTEV
Claritev Corporation
NYSE · USHealthcareMedical - Healthcare Information Services
$30.12-0.89%
Price as of Jul 20, 2026
CTEV financials
Claritev Corporation financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $965.4M | $930.6M | $961.5M | $1.1B |
| Cost of revenue | $698.8M | $239.4M | $235.5M | $204.1M |
| Gross profit | $266.6M | $691.2M | $726.1M | $875.6M |
| Operating expenses | $221.5M | $2.1B | $564.1M | $1.2B |
| Operating income | $45.1M | -$1.4B | $162.0M | -$362.7M |
| Net income | -$284.3M | -$1.6B | -$91.7M | -$572.9M |
| EBITDA | $475.4M | -$1.0B | $651.9M | $158.3M |
| Basic EPS | $-17.30 | $-101.92 | $-5.69 | $-35.87 |
| Diluted EPS | $-17.30 | $-101.92 | $-5.69 | $-35.87 |
| Balance sheet | ||||
| Cash & equivalents | $16.8M | $16.8M | $71.5M | $334.0M |
| Total assets | $4.9B | $5.2B | $7.0B | $7.4B |
| Total liabilities | $5.1B | $5.1B | $5.3B | $5.6B |
| Stockholders’ equity | -$173.9M | $84.0M | $1.7B | $1.8B |
| Total debt | $4.6B | $4.5B | $4.6B | $4.8B |
| Net debt | $4.6B | $4.5B | $4.5B | $4.4B |
| Cash flow | ||||
| Operating cash flow | $117.3M | $107.6M | $171.7M | $372.4M |
| Capital expenditure | -$129.6M | -$118.1M | -$108.9M | -$89.7M |
| Free cash flow | -$12.3M | -$10.5M | $62.9M | $282.6M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | -$10.4M | -$15.2M | -$100.0M |